PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Paradigm patent rejection, page-47

  1. 6,522 Posts.
    lightbulb Created with Sketch. 1923
    No. The most important patent is the one PAR already has approved.

    PAR may submit dozens of applications to try to expand their patent, but many of them just won’t fly. None of it is likely to be market sensitive.

    This is normal. Having owned Nanosonics for example, I have seen over the years they have filed a crapload of applications for patents, many that were rejected or simply expired before they even went through the whole process. Some were attempts to try to extend the life of their existing tech, some were in new applications.

    I think 95%+ of this effort was never even reported through the ASX. And rightly so, most people would have no idea what most of it meant anyway, which makes it amusing to see some people freak out at this.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
24.0¢ 25.0¢ 23.0¢ $101.6K 424.7K

Buyers (Bids)

No. Vol. Price($)
12 144266 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 18540 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.